Measures of Physical Activity in Parkinson’s Disease (MAPD)

Background: Previous research indicates that Physical Activity (PA) can help people with Parkinson’s (PwP) to manage their symptoms but they are less active than of the same age and in relation PA guidelines. Common measures include questionnaires or accelerometers. Accelerometers not routinely used clinical services. Little has been conducted on PwP perceived feasibility utility using body-worn Objective: This quantitative, observational study assessed concurrent validity, a questionnaire accelerometer capture newly diagnosed Parkinson’s. Methods: Twenty-four participants were recruited from service for at University Hospitals Plymouth NHS Trust, UK. The was remotely by postal, telephone email correspondence. Participants wrist-worn (GENEActiv™) one week, completed International Questionnaire (IPAQ-S) about week’s PA, Likert-style these measures. Energy expenditure (metabolic equivalents – METs) calculated compared Spearman’s correlation. Descriptive statistics summarised levels WHO guidelines based responses questionnaire. Results: sample (n=24, 17 males, 7 females; mean 72.4 years, SD ± 9.7; disease duration 1 years) showed significant moderate correlation between total weekly energy (rs = 0.55, n = 24, p =.003). Overall, above (IPAQ-S 453 mins per range 0 3010, 718); GENEActiv™ 265 - 794, 217). agreed ‘the easy fill in’ (median response 2 agree, IQR 2) disagreed statement ‘I would rather previous week wear sensor week’ 4 disagree, 2). Conclusion: Findings suggest it is feasible introduce measure patients remotely. There wide variation when determining PA. Validation device against gold standard intensity needed establish criterion validity. Impact: work contributes understanding patient experience preferences remote monitoring use plan provision support